Boston Scientific Financials

0HOY Stock   89.17  0.04  0.04%   
Financial data analysis helps to double-check if markets are presently mispricing Boston Scientific Corp. We are able to interpolate and collect twenty-four available fundamental indicators for Boston Scientific Corp, which can be compared to its peers. The stock experiences a normal upward fluctuation. Check odds of Boston Scientific to be traded at 93.63 in 90 days. Key indicators impacting Boston Scientific's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Income1.5 B2.3 B
Way Down
Slightly volatile
  
Understanding current and past Boston Scientific Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Boston Scientific's financial statements are interrelated, with each one affecting the others. For example, an increase in Boston Scientific's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Boston Scientific's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Boston Scientific Corp. Check Boston Scientific's Beneish M Score to see the likelihood of Boston Scientific's management manipulating its earnings.

Boston Scientific Stock Summary

Boston Scientific competes with Samsung Electronics, Samsung Electronics, Hyundai, Reliance Industries, and Panasonic Corp. Boston Scientific is entity of United Kingdom. It is traded as Stock on LSE exchange.
Specialization
Industrials, Commercial & Professional Services
InstrumentUK Stock View All
ExchangeLondon Exchange
Business Address300 Boston Scientific
SectorCommercial Services & Supplies
IndustryIndustrials
BenchmarkDow Jones Industrial
Websitewww.bostonscientific.com
Phone508 683 4000
You should never invest in Boston Scientific without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Boston Stock, because this is throwing your money away. Analyzing the key information contained in Boston Scientific's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Boston Scientific Key Financial Ratios

There are many critical financial ratios that Boston Scientific's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Boston Scientific Corp reports annually and quarterly.

Boston Scientific Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets30.6B30.8B32.2B32.5B35.1B26.4B
Other Current Liab2.7B2.8B2.7B2.4B3.2B2.8B
Net Debt9.8B7.7B7.4B8.2B8.7B6.5B
Retained Earnings(2.3B)(2.4B)(1.4B)(750M)819M860.0M
Accounts Payable542M513M794M862M942M543.4M
Cash563M1.9B2.1B1.1B865M927.8M
Other Assets4.6B4.5B4.6B4.6B5.3B5.5B
Net Receivables1.9B1.5B1.8B2.0B2.2B1.7B
Good Will10.2B10.0B12.0B12.9B14.4B9.6B
Inventory1.6B1.4B1.6B1.9B2.5B1.5B
Other Current Assets624M2.3B1.2B1.3B937M949.8M
Total Liab16.7B15.5B15.6B14.9B15.6B14.4B
Total Current Assets4.7B6.7B6.3B5.8B6.5B5.0B
Intangible Assets8.2B6.1B6.2B6.0B6.0B6.8B
Short Term Debt1.5B83M332M81M607M711.3M
Long Term Debt3.8B4.8B8.6B9.1B10.5B7.0B
Capital Surpluse17.2B17.3B17.6B19.7B22.7B19.5B
Other Liab3.0B2.2B2.1B1.8B1.6B1.9B
Net Tangible Assets(4.5B)(760M)(1.6B)(1.3B)(1.5B)(1.6B)

Boston Scientific Key Income Statement Accounts

201920202021202220232024 (projected)
Total Revenue10.7B9.9B11.9B12.7B14.2B10.6B
Gross Profit6.9B5.6B7.5B7.7B9.8B6.9B
Operating Income1.7B601M1.9B1.8B2.3B1.5B
Ebit1.7B389M1.8B2.0B2.4B1.5B
Research Development1.2B1.1B1.2B1.3B1.4B1.2B
Ebitda2.7B1.5B2.9B3.2B3.6B2.5B
Cost Of Revenue3.9B4.3B4.4B5.0B4.4B3.7B
Income Before Tax687M(79M)1.1B1.1B2.0B2.1B
Net Income4.7B(82M)1.0B698M1.6B1.7B
Income Tax Expense(4.0B)2M36M443M393M412.7M
Tax Provision(182M)89M2M36M41.4M43.5M
Interest Income72M831M7M341M306.9M253.1M
Interest Expense513M468M349M464M272M324.7M

Boston Scientific Key Cash Accounts

201920202021202220232024 (projected)
Change To Inventory(290M)(65M)(346M)(321M)(660M)(627M)
Change In Cash(238M)1.4B173M(1.0B)(71M)(67.5M)
Free Cash Flow1.4B1.1B1.3B938M1.8B1.1B
Depreciation1.0B1.1B1.1B1.1B1.2B1.0B
Other Non Cash Items(1.3B)27M167M13M370M652.6M
Net Income4.7B(82M)1.0B698M1.6B1.7B
End Period Cash Flow563M2.0B2.2B1.1B1.1B967.0M
Investments(149M)(146M)279M(24M)(27.6M)(29.0M)
Net Borrowings1.4B2.8B(999M)(165M)(148.5M)(141.1M)
Change To Netincome(3.6B)490M87M697M801.6M841.6M

Boston Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Boston Scientific's current stock value. Our valuation model uses many indicators to compare Boston Scientific value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Boston Scientific competition to find correlations between indicators driving Boston Scientific's intrinsic value. More Info.
Boston Scientific Corp is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.55  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Boston Scientific Corp is roughly  1.82 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Boston Scientific's earnings, one of the primary drivers of an investment's value.

Boston Scientific Corp Systematic Risk

Boston Scientific's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Boston Scientific volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Boston Scientific Corp correlated with the market. If Beta is less than 0 Boston Scientific generally moves in the opposite direction as compared to the market. If Boston Scientific Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Boston Scientific Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Boston Scientific is generally in the same direction as the market. If Beta > 1 Boston Scientific moves generally in the same direction as, but more than the movement of the benchmark.

Boston Scientific Corp Total Assets Over Time

Boston Scientific December 21, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Boston Scientific help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Boston Scientific Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Boston Scientific Corp based on widely used predictive technical indicators. In general, we focus on analyzing Boston Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Boston Scientific's daily price indicators and compare them against related drivers.

Additional Tools for Boston Stock Analysis

When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.